• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


36.5500 USD 0.2700 0.73%

As of 20:10:00 ET on 09/17/2014.

Snapshot for Akorn Inc (AKRX)

Open: 36.9000 Day's Range: 36.4500 - 37.2500 Volume: 608,557
Previous Close: 36.8200 52wk Range: 18.1650 - 39.4800 1-Yr Rtn: +94.62%

Stock Chart for AKRX

No chart data available.
  • AKRX:US 36.5500
  • 1D
  • 1M
  • 1Y
Interactive AKRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKRX

Current P/E Ratio (ttm) 76.8771
Estimated P/E(12/2014) 35.7632
Relative P/E vs. SPX 4.2517
Earnings Per Share (USD) (ttm) 0.4754
Est. EPS (USD) (12/2014) 1.0220
Est. PEG Ratio 1.2664
Market Cap (M USD) 3,806.09
Shares Outstanding (M) 104.13
30 Day Average Volume 1,307,877
Price/Book (mrq) 12.9196
Price/Sale (ttm) 8.8484
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 08/29/1991
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AKRX

Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology. Akorn also markets ophthalmic surgical instruments and other supplies, and provides contract manufacturing for third parties.

Rajat Rai "Raj"Chief Executive OfficerTimothy A Dick "Tom"CFO/Investor Relations
Bruce KutinskyChief Operating OfficerMark M SilverbergExec VP: Quality Assurance
More Company Profile & Key Executives for AKRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil